StayCurrentMD · Peri-operative Anticoagulation Strategies, Bleeding and Thrombotic Complications in Pediatric Patients Undergoing Intervention for Congenital Portosystemic Shunts
Article1 min read·Published Jun 2024Older

Peri-operative Anticoagulation Strategies, Bleeding and Thrombotic Complications in Pediatric Patients Undergoing Intervention for Congenital Portosystemic Shunts

jpedsurg.org shows its articles on its own site.

Read the article on jpedsurg.org ↗

Article · Jun 2024 · 1 min read

In brief

In brief

This study examines anticoagulation protocols and complication rates in pediatric patients undergoing interventional closure of congenital portosystemic shunts. It addresses the clinical challenge of balancing thrombotic risk in the portal venous system against bleeding complications in this rare congenital vascular anomaly population.

  • CPSS are rare vascular malformations requiring careful peri-operative anticoagulation to balance thrombosis and bleeding risk post-closure.
  • Post-intervention thrombotic complications are a key concern due to altered portal venous hemodynamics after shunt occlusion.
  • Standardized anticoagulation protocols are needed to optimize outcomes in pediatric CPSS patients undergoing interventional closure.
  • Bleeding complications must be monitored closely given the coagulopathy often present in CPSS patients with hepatic dysfunction.

Written by the GCMD Library team from the article.

Congenital portosystemic shunts (CPSS) are rare congenital abnormalities causing abnormal blood flow between the portal vein and systemic circulation. This study reports on the peri-operative anticoagulation management of CPSS patients post closure, focusing on the incidence of thrombotic and bleeding complications.

Read it at the source ↗

Try
Intelligent Search· scoped to this article · not medical adviceSearch the whole library →